In lung cancer, however, circulating IGFBP-3 has an inverse correlation with cancer risk [13], while IGFBP-3 plasma levels in prostate cancer are associated with cancer incidence and survival [14,15]. This evidence concerns the gene IGFBP3 and lung cancer.